Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model

Optimal Intermittent Administration Interval of Abaloparatide for Bone Morphogenetic Protein-Induced Bone Formation in a Rat Spinal Fusion Model

Both bone morphogenetic protein 2 (BMP-2) and abaloparatide are used to promote bone formation. However, there is no consensus about their optimal administration. We investigated the optimal administration theory for the pairing of BMP-2 and abaloparatide in a rat spinal fusion model. Group I was on...

Full description

Bibliographic Details
Main Authors: Tetsutaro Abe, Masashi Miyazaki, Noriaki Sako, Shozo Kanezaki, Yuta Tsubouchi, Nobuhiro Kaku
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
abaloparatide
bone morphogenetic protein
bone fusion
rat spinal fusion model
Online Access:https://www.mdpi.com/1422-0067/25/7/3655

Internet

https://www.mdpi.com/1422-0067/25/7/3655

Similar Items